BRIEF published on 08/07/2024 at 09:05, 3 months 14 days ago Novem Group S.A.: Invitation to the Q1 2024/25 Results Presentation on 14 August 2024 Conference Call Investor Relations Results Presentation Novem Group Q1 2024/25
PRESS RELEASE published on 08/07/2024 at 09:00, 3 months 14 days ago Novem Group S.A.: Invitation to the Q1 2024/25 results presentation on 14 August 2024 Novem Group S.A. invites investors and analysts to the Q1 2024/25 results presentation on 14 August 2024, with CEO Markus Wittmann and CFO Dr. Johannes Burtscher presenting Investors Analysts Presentation Q1 Results Novem Group
BRIEF published on 08/01/2024 at 08:02, 3 months 20 days ago Novem Group S.A.: Changes in Management Board CFO COO Management Change Board Appointments Novem Group
BRIEF published on 08/01/2024 at 08:01, 3 months 20 days ago Novem Group S.A.: Changes in Management Board Corporate Governance Management Board Leadership Change Novem Group Company News
PRESS RELEASE published on 08/01/2024 at 07:57, 3 months 20 days ago Novem Group S.A.: Changes in Management Board Novem Group S.A. announces changes in Management Board with Dr. Johannes Burtscher stepping down as CFO and Benjamin Retzer appointed CFO, Florian Sandner as COO CFO COO Management Board Novem Group S.A. Changes
PRESS RELEASE published on 08/01/2024 at 07:56, 3 months 20 days ago EQS-Adhoc: Novem Group S.A.: Changes in Management Board Novem Group S.A. announces changes in Management Board with Dr. Johannes Burtscher stepping down as Group CFO and Benjamin Retzer being promoted to CFO, along with the appointment of Florian Sandner as COO CFO COO Management Board Novem Group S.A. Succession Plan
BRIEF published on 06/27/2024 at 09:05, 4 months 24 days ago Novem Group S.A. Confirms Preliminary Results for FY 2023/24 Annual Report Revenue Decline No Dividend Novem Group FY 2023/24 Results
PRESS RELEASE published on 06/27/2024 at 09:00, 4 months 24 days ago Novem Group S.A. confirms preliminary results for FY 2023/24 Novem Group S.A. confirms FY 2023/24 results with revenue of €635.5 million, Adj. EBIT of €69.1 million, and no dividend proposed. Solid order intake supports medium-term guidance Financial Results Revenue Dividend Novem Group S.A. FY 2023/24
BRIEF published on 06/17/2024 at 17:25, 5 months 3 days ago Novem Group S.A. Announces Suspension of Dividend Annual General Meeting Economic Uncertainty Dividend Suspension Novem Group 2023/24
PRESS RELEASE published on 06/17/2024 at 17:20, 5 months 3 days ago EQS-Adhoc: Novem Group S.A.: Suspension of dividend Novem Group S.A. announces suspension of dividend for financial year 2023/24 due to economic uncertainties and market conditions Market Conditions Financial Year 2023/24 Novem Group S.A. Dividend Suspension Economic Uncertainties
Published on 11/21/2024 at 13:30, 17 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 17 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 47 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 47 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 47 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 12 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 32 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 49 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 27 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 2 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 2 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
